GoodRx Holdings (GDRX) Cash from Investing Activities (2019 - 2026)

GoodRx Holdings has disclosed Cash from Investing Activities across 8 years of filings, most recently posting -$14.4 million for Q2 2026.

• In Q2 2026, Cash from Investing Activities rose 21.33% year-over-year to -$14.4 million; the TTM figure through Jun 2026 stood at -$85.8 million (up 16.43% YoY), while the FY2025 annual figure was -$120.0 million, down 70.53% from the prior year.
• Cash from Investing Activities came in at -$14.4 million for Q2 2026 at GoodRx Holdings, up from -$21.6 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $1.3 million in Q4 2022 to a low of -$163.6 million in Q2 2022.
• Average Cash from Investing Activities over 5 years is -$27.4 million, with a median of -$16.9 million recorded in 2024.
• Year-over-year, Cash from Investing Activities soared 113.89% in 2022 and plunged 1100.93% in 2023.
• Over 5 years, Cash from Investing Activities stood at $1.3 million in 2022, then sank by 1100.93% to -$12.9 million in 2023, then retreated by 29.3% to -$16.6 million in 2024, then sank by 90.88% to -$31.8 million in 2025, then surged by 54.65% to -$14.4 million in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were -$14.4 million in Q2 2026, -$21.6 million in Q1 2026, and -$31.8 million in Q4 2025.